The main underlying factor in the pathogenesis of wet AMD is the formation of new vessels in the choroid layer.3 The introduction of vascular endothelial growth factor (VEGF) inhibitor therapy into clinical practice has dramatically altered the prognosis of wet AMD. Here, VEGFA is linked to wet macular degeneration.